Simonian Nancy A is a director of Seagen Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Syros Pharmaceuticals, Inc.
2 Apr 24
4
Seagen Inc.
15 Dec 23
4
Syros Pharmaceuticals, Inc.
5 Dec 23
4
Syros Pharmaceuticals, Inc.
2 Nov 23
4
Seagen Inc.
2 Jun 23
4
Syros Pharmaceuticals, Inc.
4 Apr 23
4
Syros Pharmaceuticals, Inc.
21 Feb 23
4
Seagen Inc.
14 Dec 22
4
Syros Pharmaceuticals, Inc.
11 Oct 22
4
Seagen Inc.
17 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | SYRS Syros Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 5.12 | 14,052 | 71.95 k | 131,658 |
31 Mar 24 | SYRS Syros Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 39,566 | 0.00 | 145,710 |
31 Mar 24 | SYRS Syros Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,000 | 0.00 | 106,144 |
31 Mar 24 | SYRS Syros Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 39,566 | 0.00 | 79,134 |
31 Mar 24 | SYRS Syros Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,000 | 0.00 | 12,000 |
14 Dec 23 | SGEN Seagen | Common Stock | Sale back to company | Dispose D | No | No | 229 | 62,753 | 14.37 mm | 0 |
14 Dec 23 | SGEN Seagen | RSU Common stock | Sale back to company | Dispose D | No | No | 0 | 2,044 | 0.00 | 0 |
14 Dec 23 | SGEN Seagen | Stock Options Common stock | Sale back to company | Dispose D | No | No | 135.63 | 3,676 | 498.58 k | 0 |
14 Dec 23 | SGEN Seagen | Stock Options Common stock | Sale back to company | Dispose D | No | No | 147.5 | 3,462 | 510.65 k | 0 |
14 Dec 23 | SGEN Seagen | Stock Options Common stock | Sale back to company | Dispose D | No | No | 160.33 | 3,171 | 508.41 k | 0 |